S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

GLMD Galmed Pharmaceuticals Ltd

3.05

-0.02 (-0.65%)

Dec 20 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Galmed Pharmaceuticals (NASDAQ:GLMD)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Galmed Pharmaceuticals Charts.

Galmed Pharmaceuticals (NASDAQ:GLMD)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Galmed Pharmaceuticals Charts.

Galmed Pharmaceuticals Ltd News

Form EFFECT - Notice of Effectiveness
Thursday 21 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form F-3 - Registration statement by foreign private issuers
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 28 October 2024 (2 months ago) • Edgar (US Regulatory)

Form F-1 - Registration statement for certain foreign private issuers
Monday 21 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 21 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 15 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 25 September 2024 (3 months ago) • Edgar (US Regulatory)

Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology
Wednesday 25 September 2024 (3 months ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 20 September 2024 (3 months ago) • Edgar (US Regulatory)

More Galmed Pharmaceuticals Ltd News Articles

Elite Pharmaceuticals (QB)

Voip Pal Com (QB)

Northwest Biotherapeutics (QB)

Digital Brand Media and ... (PK)

North Bay Resources (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions